Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Net Cash Flow: 2019-2025

Historic Net Cash Flow for IDEAYA Biosciences (IDYA) over the last 7 years, with Sep 2025 value amounting to $184.3 million.

  • IDEAYA Biosciences' Net Cash Flow fell 15.17% to $184.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$101.5 million, marking a year-over-year decrease of 140.81%. This contributed to the annual value of -$72.6 million for FY2024, which is 181.53% down from last year.
  • IDEAYA Biosciences' Net Cash Flow amounted to $184.3 million in Q3 2025, which was up 1,300.46% from -$15.4 million recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Net Cash Flow ranged from a high of $217.2 million in Q3 2024 and a low of -$316.0 million during Q4 2024.
  • Over the past 3 years, IDEAYA Biosciences' median Net Cash Flow value was $36.2 million (recorded in 2023), while the average stood at $21.0 million.
  • In the last 5 years, IDEAYA Biosciences' Net Cash Flow soared by 4,539.07% in 2021 and then slumped by 6,173.63% in 2024.
  • Quarterly analysis of 5 years shows IDEAYA Biosciences' Net Cash Flow stood at -$16.4 million in 2021, then crashed by 103.41% to -$33.3 million in 2022, then spiked by 115.61% to $5.2 million in 2023, then plummeted by 6,173.63% to -$316.0 million in 2024, then declined by 15.17% to $184.3 million in 2025.
  • Its Net Cash Flow stands at $184.3 million for Q3 2025, versus -$15.4 million for Q2 2025 and $45.6 million for Q1 2025.